PortfoliosLab logo

bluebird bio, Inc. (BLUE)

Equity · Currency in USD · Last updated Mar 28, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in bluebird bio, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $2,589 for a total return of roughly -74.11%. All prices are adjusted for splits and dividends.


-50.00%0.00%50.00%100.00%150.00%NovemberDecember2023FebruaryMarch
-74.11%
151.50%
BLUE (bluebird bio, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BLUE

bluebird bio, Inc.

Popular comparisons: BLUE vs. SCHD

Return

bluebird bio, Inc. had a return of -34.83% year-to-date (YTD) and -9.44% in the last 12 months. Over the past 10 years, bluebird bio, Inc. had an annualized return of -12.94%, while the S&P 500 had an annualized return of 9.92%, indicating that bluebird bio, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-11.91%0.19%
Year-To-Date-34.83%3.59%
6 months-19.75%7.70%
1 year-9.44%-9.82%
5 years (annualized)-47.61%9.44%
10 years (annualized)-12.94%9.92%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-8.24%-18.11%
20228.39%-0.95%24.24%-11.17%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current bluebird bio, Inc. Sharpe ratio is -0.09. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.200.000.20NovemberDecember2023FebruaryMarch
-0.09
-0.35
BLUE (bluebird bio, Inc.)
Benchmark (^GSPC)

Dividend History


bluebird bio, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2023FebruaryMarch
-97.01%
-14.59%
BLUE (bluebird bio, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the bluebird bio, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the bluebird bio, Inc. is 98.05%, recorded on May 24, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.05%Mar 13, 20181059May 24, 2022
-81.36%Jun 1, 2015241May 12, 2016399Dec 11, 2017640
-49.91%Jul 17, 201389Nov 19, 2013143Jun 17, 2014232
-25.15%Jun 23, 201417Jul 16, 201471Oct 24, 201488
-19.58%Jan 15, 201517Feb 9, 201517Mar 5, 201534
-19.05%Dec 12, 201723Jan 16, 20186Jan 24, 201829
-12.64%Mar 20, 20154Mar 25, 201512Apr 13, 201516
-8.03%Jan 25, 201811Feb 8, 20185Feb 15, 201816
-7.91%Nov 11, 20144Nov 14, 20146Nov 24, 201410
-7.5%Nov 25, 20144Dec 1, 20142Dec 3, 20146

Volatility Chart

Current bluebird bio, Inc. volatility is 47.09%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%NovemberDecember2023FebruaryMarch
47.09%
17.88%
BLUE (bluebird bio, Inc.)
Benchmark (^GSPC)